Lin BioScience, Inc.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.linbioscience.com
The Safety and Tolerability of LBS-007 in Patients with Relapsed or Resistant Acute Leukaemias
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Lin BioScience, Inc
- Target Recruit Count
- 90
- Registration Number
- NCT05756322
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇦🇺Wollongong Private Hospital, Wollongong, New South Wales, Australia
🇦🇺Pindara Private Hospital, Benowa, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath